Gene therapy for inherited neurological disorders: Towards therapeutic intervention in the Lesch-Nyhan syndrome

Progress in Brain Research

Volumn 117, Issue , 1998, Pages 485-501

  Lowenstein, P R ^a   Southgate, T D ^a   Smith Arica, J R ^a   Smith, J ^a   Castro, M G ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; COMPLEMENTARY DNA; DOXYCYCLINE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL MODEL; CONFERENCE PAPER; DOPAMINERGIC NERVE CELL; GENE THERAPY; GENE TRANSFER; GENETIC DISORDER; HUMAN; HUMAN CELL; HYPERURICEMIA; LESCH NYHAN SYNDROME; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0031740492     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0079-6123(08)64034-0     Document Type: Conference Paper

References (113)

1. M.D. Bell D.D. Taub S.J. Kunkel R.M. Striter R. Foley J. Gauldie V.H. Perry Recombinant human adenovirus with Rat MIP-2 gene insertion causes prolonged PMN recruitment to the murine brain European Journal of Neuroscience 8 1996 1803 1811
2. G. Bernardi The human genome-organization and evolutionary history Annual Review of Genetics 29 1995 445 476
3. A. Bilang-Bleuel F. Revah P. Colin I. Locquet J.J. Robert J. Mallet P. Horellou Instrastriatal injection of an adenoviral vector expressing glial-cell line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behaviora impairment in a rat model of Parkinson's disease Proceedings of the National Academy of Sciences, USA 94 1997 8818 8823
4. U. Blomer L. Naldini T. Kafri D. Trono I.M. Verma F.H. Gage Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector Journal of Virology 71 1997 6641 6649
5. M. Bornens J. Camonis B. Goud J.P. Thiery D. Louvard The new-age of the cell Medecine/Sciences 12 1996 50 66
6. V.A. Boussiotis G.J. Freeman J.G. Gribben L.M. Nadler The role of B7–1/B7–2:CD28/CTLA4 pathways in the prevention of anergy, induction of productive immunity and down regulation of the immune response Immunological Reviews 153 1996 5 26
7. G.R. Breese H.E. Criswell G.E. Duncan R.A. Mueller A dopamine deficiency model of Lesch-Nyhan disease – the neonatal 6-OHDA-lesioned rat Brain Research Bulletin 25 1990 477 484
8. O.A. Brown R.M. Santer A.F. Shering A.T. Larregina A.E. Morelli T.D. Southgate M.G. Castro P.R. Lowenstein Gene transfer into enteric neurons of the rat small intestine in organ culture using a replication defective recombinant herpes simplex virus type 1 (HSV1) vector, but not recombinant adenovirus vectors Gene Therapy 4 1997 331 338
9. A.P. Byrnes R.E. Maclaren H.M. Charlton Immunological instability of persistent adenovirus vectors in the brain: Peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination Journal of Neuroscience 16 1996 3045 3055
10. A.P. Byrnes J.E. Rusby M.J.A. Wood H.M. Charlton Adenovirus gene transfer causes inflammation in the brain Neuroscience 66 1995 1015 1024
11. A.P. Byrnes M.J.A. Wood H.M. Charlton Role of T cells in inflammation caused by adenovirus vectors in the brain Gene Therapy 3 1996 644 651
12. M.G. Castro R.G. Goya Y.E. Sosa J. Rowe A. Larregina A. Morelli P.R. Lowenstein Expression of transgenes in normal and neoplastic anterior pituitary cells using recombinant adenoviruses: Long term expression, cell cycle dependency, and effects on hormone secretion Endocrinology 138 1997 2184 2194
13. C.A. Chambers M.F. Krummel B. Boitel A. Hurwitz T.J. Sullivan S. Fournier D. Cassell M.J.P. Brunner Allison The role of CTLA-4 in the regulation and initiation of T-cell responses Immunological Reviews 153 1996 27 26
14. Chiocca E.A. Breakfield X.O. Gene therapy for neurological disorders and brain tumors 1997 Humana Press Totowa, New Jersey, USA 458
15. D.L. Choi-Lundberg Q. Lin Y.N. Chang Y.L. Chiang C.M. Hey H. Mohaheri B.L. Davidson M.C. Bohn Dopaminergic neurons protected from degeneration by GDNF gene therapy Science 275 1997 838 841
16. Cohen S. Construction of biologically functional bacterial plasmids in vitro Proceedings of the National Academy of Sciences, USA 70 1973 3240 3244
17. B.L. Davidson S.E. Doran D.S. Shewach J.M. Latta J.W. Hartman B.J. Roessler Expression of Escherichia coli β-galactosidase and rat HPRT in the CNS os Macaca mulatta following adenoviral mediated gene transfer Experimental Neurology 125 1994 258 267
18. N. Deglon B. Heyd S.A. Tan J.M. Joseph A.D. Zum P. Aebischer Central nervous system delivery of recombinant ciliary neurotrophic factor by polymer encapsulated differentiated C2C12 myoblasts Human Gene Therapy 7 1996 2135 2146
19. R.P. DeMatteo J.F. Markmann K.F. Kozarsky C.F. Barker S.E. Raper Prolongation of adenoviral transgene expression in mouse liver by T lymphocyte subset depletion Gene Therapy 3 1996 4 12
20. C.W. Dykes Genes, disease and medicine. Britis Journal of Clinical Pharmacology 42 1996 683 695
21. K.B. Elkon L. Chau-Ching J.G. Gall J. Trevejo M.W. Marino K.A. Abrahamsen X. Song J.L. Zhou L.J. Old R.G. Crystal Tumor necrosis factor α plays a central role inimmune-mediated clearance of adenoviral vectors Proceedings of the National Academy of Sciences, USA 94 1997 9814 9819
22. G. Elliott P. O' Hare Intercellular trafficking and protein delivery by a herpesvirus structural protein Cell 88 1997 223 233
23. S.J. Engle D.E. Womer P.M. Davies G. Boivin A. Sahota H.A. Smmonds P.J. Stambrook J.A. Tischfield HPRT-APRT-deficient mice are not a model for Lesch-Nyhan syndrome Human Molecular Genetics 5 1996 1607 1610
24. M. Ernst A. Zametkin J.A. Matochik D. Pascualvaca P.H. Jons K. Hardy J.G. Hankerson D.J. Doudet R.M. Cohen Presynaptic dopaminergic deficits in Lesch-Nyhan disease The New England Journal of Medicine 334 1996 1568 1572
25. J. Fearnley A. Lees Pathology of Parkinsonis Disease Donald B. Calne D.M. Neurodegenerative Diseases 1996 W. B. Saunders Company, Publisher 545 554
26. L.M. Fisher F.H. Gage Intracerebral transplantation. Basic and clinical applicatins to the neostriatum FASEB Journal 8 1994 489 496
27. A. Fontana K. Frei S. Bodmer E. Hofer M.H. Schreier Palladino A. Jr. R.M. Zinkernagel Transforming growth factor-β inhibits the generation of cytotoxic T cells in virus-infected mice Journal of Immunology 143 1989 3230 3234
28. A. Freese M. Stern M.G. Kaplitt W.M. O' Connor M.V. Abbey M.J. O' Connor M.J. During Prospects for gene therapy in Parkinson's disease Movement Disorders 11 1996 469 488
29. S. Freundlieb U. Baron A.L. Bonin M. Gossen H. Bujard Use of tetracycline-controlled gene expression systems to study mammalian cell cycle Methods in Enzymology 283 1997 159 173
30. T. Friedmann R. Roblin Gene therapy for human genetic disease Science 175 1972 949 955
31. B.J. Geddes T.C. Harding D.S. Hughes A.P. Byrnes S.L. Lightman G. Conde J.B. Uney Persistent transgene expression in the hypothalamus following stereo-taxic delivery of a recombinant adenovirus – suppression of the immune-response with cyclosporine Endocrinology 137 1996 5166 5169
32. M. Gossen H. Bujard Tight control of gene expression in mammalian cells by tetracycline-responsive elements Proceedings of the National Academy, USA 89 1992 5547 5551
33. B. Guerette J.T. Vilquin M. Gingras C. Gravel K.J. Tremblay Wood Prevention of immune reactions triggered by first-generation adenoviral vectors by monoclonal antibodies and CTLA4Ig Human Gene Therapy 7 1996 1455 1463
34. W.T.J.M.C. Hermens J. Verhaagen Adenoviral vector-mediated gene expression in the nervous system of immunocompetent Wistar and T cell-deficient nude rats: preferential survival of transduced astroglial cells in nude rats Human Gene Therapy 8 1997 1049 1063
35. M. Hooper K. Hardy A. Handyside S. Hunter M. Monk HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells 326 1987 292 295
36. D.M. Hunt S.S. Bhattacharya Co-injection of adenovirus expression CTLA4-Ig prolongs adenovirally-mediated lacZ reporter gene expression in the mouse retina Investigative Ophthalamology and Visual Science 38 1997 1198 Pt1.
37. Y. Ilan V.K. Jona K. Sengupta A. Davidson M.S. Horwitz N.R. Chowdhury J.R. Chowdhury Transient immunosuppression with FK506 permits long-term expression of therapeutic genes introduced into the liver using recombinant adenoviruses in the rat Hepatology 26 1997 949 956
38. O. Isacson T. Deacon Neural transplantation studies reveal the brain is capacity for continuous reconstruction Trends in Neurosciences 20 1997 477 482
39. D.A. Jackson R.H. Symons P. Berg Biochemical method for inserting new genetic information into DNA of simian virus 40: Circular SV40 DNA molecules containing lambda phage genes and the galactose operon o E. Coli., Proceedings of the National Academy of Sciences, USA 69 1972 2904 2909
40. H.A. Jinnah F.H. Gage T. Friedmann Animal models of Lesch-Nyhan syndrome Brain Research Bulletin 25 1990 467 475
41. H.A. Jinnah F.H. Gage T. Friedmann Amphetamine-induced behavioural phenotype in a hypoxanthine-guanine phosphoribosyltransferase-deficient mouse model of Lesch-Nyhan syndrome Behavioral Neuroscience 105 1991 1004 1012
42. H.A. Jinnah E.J. Hess M.C. Wilson F.H. Gage T. Friedmann Localization of hypoxanthine-guanine-phosphoribosyltransferase mRNA in the mouse brain by in situ hybridization Molecular and Cellular Neuroscience 3 1992 64 78
43. H.A. Jinnah P.J. Langlais T. Friedmann Functional analysis of brain dopamine systems in a genetic mouse model of Lesch-Nyhan syndrome Journal of Pharmacology and Experimental Therapeutics 263 1992 596 607
44. H.A. Jinnah Page T. T. Friedmann Brain purines in a genetic mouse model of Lesch-Nyhan disease Journal of Neurochemistry 60 1993 2036 2045
45. H.A. Jinnah B.E. Wojcik M. Hunt N. Narang K.Y. Lee M. Goldstein J.K. Wamsley P.J. Langlais T. Friedmann Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease Journal of Neuroscience 14 1994 1164 1175
46. D.J. Jolly H. Okayama P. Berg A.C. Esty D. Filpula P. Bohlen G.G. Johnson J.E. Shively T. Hunkapillar T. Friedmann Isolation and characterization of a full-lengths expressible cDNA for human hypoxanthine phosphoribosyltransferase Proceedings of the National Academy of Sciences, USA 80 1983 477 481
47. K. Jooss Y.P. Yang J.M. Wilson Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung Human Gene Therapy 7 1996 1555 1566
48. J.N. Joyce P.A. Frohna B.S. Neal-Beliveau Functional and molecular differentiation of the dopamine system induced by neonatal denervation Neuroscience and Biobehavioral Reviews 20 1996 453 486
49. Viral vectors Kaplitt M.G. Loewy A.D. Gene therapy and neuroscience applications 1995 Academic Press San Diego, USA 486
50. M.A. Kay L. Meuse A.M. Gown P. Linsley D. Hollenbaugh A. Aruffo H.D. Ochs C.B. Wilson Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver Proceedings of the National Academy of Sciences, USA 94 9 1997 4686 4691
51. Kay M. Long-term hepatic adenovirus-mediated gene expression in mice following CTLAIg administration Nature 11 1995 191 197
52. Kay M. Transient immunomodulation with anti-CD40 Ig enhances persistence and secondary adenovirus mediated gene transfer into mouse liver Proceedings of the National Academy of Sciences, USA 93 1997 4686 4691
53. W.N. Kelley F.M. Rosenbloom J.F. Henderson J.E. Seegmiller A specific enzyme defect in gout associated with overproduction of uric acid Proceedings of the National Academy of Sciences, USA 1967 1734 1739
54. J. King Ching Tsui Treatment of Parkinsonis Disease Donald B. Calne D.M. Neurodegenerative Diseases 1996 W.B. Saunders Company, Publisher 573 582
55. V.E. Koliatsos Biological therapies for Alzheimer's disease: focus on trophic factors Critical Reviews in Neuro-biology 10 1996 205 238
56. E.H. Kolodny A.L. Fluharty Metachromatic leukodystrophy and multiple sulfatase deficiency: sulfatide lipidosis Scriver C.R. Beaudet A.L. Sly W.S. Valle D. The Metabolic and Molecular Bases of Inherited Disease Seventh Edition 1995 Mc Graw Hill, Inc. New York 2693 2739
57. M.R. Kuehn A. Bradley E.J. Roberton M.J. Evans A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice Nature 326 1987 295 299
58. P. Lane Regulation of T and B cell responses by modulating interactions between CD28/CTLA4 and their ligands, CD80 and CD86 Annals of the New York Academy Science 815 1997 392 400
59. C.P. Larsen E.T. Elwood D.Z. Alexander S.C. Ritchie R. Hendrix C. Tuckerburden H.R. Cho A. Aruffo D. Hollenbaugh P.S. Linsley K.J. Winn T.C. Pearson Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways Nature 381 1996 434 438
60. J. Lederberg Tomorrow's babies Proceedings of the Sixth World Congress on Fertility and Sterility 1968 18 23
61. D.J. Lenschow T.L. Walunas J.A. Bluestone CD28/B7 system of T cell costimulation Annual Review of Immunology 14 1996 233 258
62. M. Lesch W.L. Nyhan A familial disorder of uric acid metabolism and central nervous system function American Journal of Medicine 36 1964 561 570
63. A. Lieber C.Y. He L. Meuse D. Schowalter I. Kirillova B. Winther M.A. Kay The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors Journal of Virology 71 1997 8798 8807
64. K.G. Lloyd O. Hornykiewicz L. Davidson K. Shannak I. Farley M. Goldstein W.N. Shibuya Kelley I.H. Fox Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome New England Journal of Medicine 5 1981 1106 1111
65. Protocols for Gene Transfer in Neuroscience Lowenstein P.R. Enquist L. Towards Gene Therapy of Neurological Disorders 1996 John Wiley & Sons Chichester 417
66. P.R. Lowenstein A.F. Shering D. Bain M.G. Castro G.W.G. Wilkinson The use of adenovirus vectors to transfer genes into identified target brain cells in-vitro Lowenstein P.R. Enquist L.W. Protocols for Gene Transfer in Neuroscience: Towards Gene Therapy of Neurological Disorders 1996 John Wiley and Sons Chichester 93 114
67. P.R. Lowenstein Editorial: Why are we doing so much cancer gene therapy? Disentangling the scientific basis from the origins of gene therapy Gene Therapy 4 1997 755 756
68. Lowenstein P.R. Enquist L.W. Protocols for gene transfer in neuroscience: Towards gene therapy of neurological disorders 1996 John Wiley and Sons Chichester, UK 417
69. T. Maniatis Signal transduction – Catalysis by a multiprotein I kappa B kinase complex Science 278 1997 818 819
70. R. Mann R. Mulligan D. Baltimore Construction of a retrovirus packaging mutant and its use to produce helper-free defective retroviruses Cell 33 1983 153 159
71. G.M. McCreanor R.A. Harkness Lesch-Nyhan syndrome and its pathogenesis: Normal nicotinamide-adenine dinucleotide but reduced ATP concentrations that correlate with reduced poly ADP-ribose) synthetase ativity in HPRT-deficient lymphoblasts Journal of Inherited Metabolic Disorders 18 1995 737 747
72. F. Mercurio H. Zhu B.W. Murray A. Schevchenko B.L. Bennett J. Li D.B. Young M. Barbosa M. Mann A. Manning A. Rao IKK-1 and IKK-2: cytokine-activated IkB kinases essential for NF-kB activation Science 278 1997 860 866
73. C.R. Merrill M.R. Geier J.C. Petricciani Bacterial virus gene expression in human cells Nature 233 1971 398 400
74. N. Miao M. Wag J.A. Ott J.S. DiAlessandro T.M. Woolf N.K. Bumcrot Mahanthappa K. Pang Sonic hedgehog promotes the survival of specific CNS neuron populations and protects these cells from toxic insult in-vitro Journal of Neuroscience 17 1997 5891 5899
75. A.D. Miller D.J. Jolly T. Friedmann I.M. Verma A transmissible retrovirus expressing human hypoxanthine phosphoribosyltransferase (HPRT): Gene transfer into cells obtained from humans deficient in HPRT Proceedings of the National Academy of Sciences, USA 80 1983 4709 4713
76. R.L. Neve J.R. Howe S. Hong R.G. Kalb Introduction of the glutamate receptor subunit 1 into motor neurons in vitro and in vivo using a recombinant herpes simplex virus Neuroscience 79 1997 435 447
77. T.D. Palella Y. Hidaka L.J. Silverman M. Levine J. Glorioso W.N. Kelley Expression of human HPRT mRNA in brains of mice infected with a recombinant herpes simplex virus-1 vector Gene 80 1989 137 144
78. T.D. Palella L.J. Silverman C.T. Schroll F.L. Homa M. Levine W.N. Kelley Herpes simplex virus-mediated human hypoxanthine-guanine phosphoribosyl-transferase gene transfer into neuronal cells Molecular and Cellular Biology 8 1988 457 460
79. P.F. Petnchev M.T. Vanier K. Suzuki M.C. Patterson Niemann-Pick disease type C: A cellular cholesterol lipidosis Scriver C.R. Beaudet A.L. Sly W.S. Valle D. The Metabolic and Molecular Bases of Inherited Disease Seventh Edition 1995 Mc Graw Hill, Inc. New York 2625 2639
80. T.J. Plumb A. Bosch B.J. Roessler D.S. Shewach B.L. Davidson Hypoxanthine-guanine phosphoribosyltransferase (HPRT) expression in the central nervous system of HPRT-deficient mice following adenoviral-mediated gene transfer Neuroscience Letters 214 1996 159 162
81. A. Prochiantz Getting hydrophilic compounds into cells. Lessons from homeopeptides Current Opininon in Neurobiology 6 1996 629 634
82. Rosenberg R.N. Prusiner S.B. DiMauro S. Barchi R.L. Kunkel L.M. The Molecular and Genetic Basis of Neurological Disease 2nd edition. 1997 John Wiley and Sons
83. B.J.F. Rossiter C.T. Caskey Hypoxanthine-guanine phosphoribosyltransferase deficiency: Lesch-Nyhan syndrome and gout Scriver C.R. Beaudet A.L. Sly W.S. Valle D. The Metabolic and Molecular Bases of Inherited Disease Seventh Edition. 1995 Mc Graw Hill, Inc. New York 1679 1706
84. J. Sambrook H. Westphal P.R. Srinivasan R. Dulbecco The integrated state of viral DNA in SV40-transformed cells Proceedings of the National Academy of Sciences, USA 60 1968 1288 1295
85. D.B. Schowaller L. Meuse C.B. Wilson P.S. Linsley M.A. Kay Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expression Gene Therapy 4 1997 853 860
86. J.E. Seegmiller F.M. Rosenbloom W.N. Kelley Enzyme defect associated with a sex linked human neurological disorder and excessive purine synthesis Science 1967 1682 1683
87. K.S. Sege-Peterson W.L. Nyhan Lesch-Nyhan disease and hypoxanthine-guanine phosphoribosyltransferase deficiency R.N. Rosenberg S.B. Prusiner S. DiMauro R.L. Barchi L.M. Kunkel The Molecular and Genetic Basis of Neurological Disease 2nd edition 1997 John Wiley and Sons 1233 1252
88. A.F. Shering D. Bain K. Stewart A.L. Epstein M.G. Castro G.W.G. Wilkinson P.R. Lowenstein Cell type-specific expression in brain cell cultures from a short human cytomegalovirus major immediate early promoter depends on whether it is inserted into herpesvirus or adenovirus vectors Journal of General Virology 78 1997 445 459
89. K. Shimotohno H.M. Temin Formation of infections progeny virus after insertion of herpes simplex thymidine kinase gene into DNA of an avian retrovirus Cell 26 1981 67 77
90. R.L. Smith G.H. Clayton C.L. Wilcox K.W. Escudero K.J. Staley Differential expressin of an inwardly rectifying chloride conductance in rat brain neurons. A potential mechanism for cell specific modulation of postsynaptic inhibition Journal of Neuroscience 15 1995 4057 4067
91. E.Y. Snyder J.D. Mackliss Multipotent neural progenitor or stem-like cells may be uniquely suited for therapy for some neuerodegenerative conditions Clinical Neuroscience 3 1996 310 316
92. E.Y. Snyder C. Yoon J.D. Flax J.D. Macklis Multipotent neural precursors can differentiate toward replacement of neurons undergoing targeted apoptotic - degeneration in adult mouse neocortex Proceedings of the National Academy of Sciences, USA 94 1997 11663 11668
93. F. Sohrabji R.C. Miranda Hormone replacement: therapeutic strategies in the treatment of Alzheimer's disease and ageing-related cognitive disorders Expert Opinion on Therapeutic Patents 7 1997 611 629
94. W. Song H.L. Kong P. Traktman R.G. Crystal Cytotoxic Tlymphocyte responses to proteins encoded by heterologous transgenes transferred in vivo by adenoviral vectors Human Gene Therapy 8 1997 1207 1217
95. T.D. Southgate D. Bain A.M. Morelli A.T. Larregina A.H. Simmonds A. Fairbanks Castro M.G.P.R. Lowenstein A replication deficient adenovirus expressing human HPRT rescues the altered phenotype of HPRT-negative fibrobalsts, and allows survival of 100% of cells in a negative selection medium Journal of Clinical Investigation 1997 Submitted
96. C.J. Tabin J.W. Hoffmann S.P. Goff R.A. Weinberg Adaptation of a retrovirus as a eucaryotic vector transmitting the herpes simplex virus thymidine kinase gene Molecular and Cellular Biology 2 1982 426 436
97. E.L. Tatum Molecular biology, nucleic acids and the future of medicine Perspectives in Biology and Medicine 10 1966 19 32
98. S. Thompson A.R. Clarke A.M. Pow M.L. Hooper D.W. Melton Germline transmission and expression of a corrected HPRT gene produced by gene targeting in embryonic stem cells Cell 56 1989 313 321
99. K. Uchida H. Hamada H. Takagi Evidence that the adenoviral vector containing CTLA4-Ig gene improves transgene expression and graft survival Transplantation Proceedings 29 1997 1738 1739
100. R.W.E. Watts E. Spellacy D.A. Gibb J. Allsop R.O. McKeran G.E. Slavin Clinical, post-mortem, bio-chemical and therapeutic observations on the Lesch-Nyhan syndrome with particular reference to the neurological manifestations Quarterly Journal of Medicine, New Series LI 201 1982 43 78
101. C.M. Wei M. Gibson P.G. Spear E.M. Scolnick Construction and isolation of a transmissible retrovirus containing the src Gene of harvey murine sarcoma virus and the thymidine kinase gene of herpes simplex virus type 1 Journal of Virology 39 1981 935 944
102. R.C. Willis D.J. Jolly A.D. Miller M.M. Plent A.C. Esty P.J. Anderson H.C. Chang O.W. Jones J.E. Seegmiller T. Friedmann Partial phenotypic correction of human Lesch-Nyhan (hypoxanthine-guanine phosphor-ibosyltransferase-deficient) lymphobasts with a transmissible retroviral vector Journal of Biological Chemistry 259 1984 7842 7849
103. G. Wolff S. Worgall N. van Rooijen W.R. Song E.G. Harvey R.G. Crystal Enhancement of in-vivo adenovirus mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ Journal of Virology 71 1997 624 629
104. J.A.J. Wolff Lederberg An early history of gene-transfer and therapy Human Gene Therapy 5 1994 469 480
105. D.F. Wong J.C. Harris S. Naidu F. Yokoi S. Marenco R.F. Dannals M. Yaster A. Evans O. Rousset N.R. Bryan Giedde A.M.J. Kuhar G.R. Bresse Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo Proceeding of the National Academy of Sciences, USA 93 1996 5539 5543
106. S. Worgall G. Wolff E. Falck-Pedersen R.G. Crystal Innate immune mechanisms dominate elimination of adenoviral vectors following in-vivo administration Human Gene Therapy 8 1997 37 44
107. J.D. Woronicz X. Gao Z. Cao M. Rothe D.V. Goeddel IkB kinase-β: NF-kB activation and complex formation with IkB kinase-a and NIK Science 278 1997 866 869
108. C.L. Wu D.W. Melton Production of a model for Lesch Nyhan syndrome in hypoxanthine phosphoribosyl-transferase-deficient mice Nature Genetics 3 1993 235 240
109. C.L. Wu D.W. Melton Production of a model for Lesch-Nyhan syndrome in hypoxanthine phosphoribosyl-transferase-deficient mice Nature Genetics 3 1993 235 240
110. X. Xiao J. Li T.J. McCown R.J. Samulski Gene transfer by adeno-associated virus vectors into the central nervous system Experimental Neurology 144 1997 113 124
111. K. Yang G.L.R.L. Clifton Hayes Gene therapy for central nervous system injury: The use of cationic liposomes: An invited review Journal of Neurotrauma 14 5 1997 281 297
112. Y. Yang F.A. Nunes K. Berencsi E.E. Furth E. Gonczol J.M. Wilson Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy Proceedings of the National Academy of Sciences, USA 91 1994 4407 4411
113. Y. Yang J.M. Wilson Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+CTLs in-vivo Journal of Immunology 155 1995 2564 2570